EvansHE. Public policy and AIDS. Clinics in Perinatology1994;21: 29–38.
2.
Council on Ethical and Judicial Affairs. Ethical issues involved in the growing AIDS crisis. Journal of the American Medical Association1988;259: 1360–1361.
3.
GostinL. The AIDS litigation project. A national review of court and human rights commission decisions. Part II. Discrimination. Journal of the American Medical Association1990;263: 2086–2093.
4.
GostinL. A human rights framework for evaluating AIDS policies: consent, confidentiality, and antidiscrimination. In: DeVitaVTJr eds. AIDS: Etiology, Diagnosis, Treatment, and Prevention. 3rd end.Philadelphia: Lippincott, 1992: 489–495.
5.
BayerR. Screening and AIDS: the limits of coercive intervention. Annals of the New York Academy of Science1988;530: 159–162.
6.
RosnerFBrennesselDJ. Ethical issues in AIDS and HIV infections. In: RapozaN, ed. HIV Infection and Disease. Chicago: American Medical Association, 1989: 193–202.
7.
Health and Policy Committee, American College of Physicians, and Infectious Diseases Society of America. The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV). Annals of Internal Medicine1988;108: 460–469.
8.
AnnasG J. Not saints, but healers: The legal duties of health care professionals in the AIDS epidemic. American Journal of Public Health1988;78: 844–849.
9.
LoBSteinbrookR. Health care workers infected with the human immunodeficiency virus: the next steps. Journal of the American Medical Association1992;267: 1100–1105.
10.
Centers for Disease Control (CDC). Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood borne pathogens in health care settings. MMWR CDC Surveillance Summaries1988;37: 377–382, 387–388.
11.
WachterRM. The impact of the acquired immunodeficiency syndrome on medical residency training. New England Journal of Medicine1986;314: 177–180.
12.
WidmanMLightDWPiattJJ. Barriers to out-of-hospital care for AIDS patients. AIDS Care1994;6: 59–67.
13.
ClarkCCurleyAHughesFAJamesR. Hospice care: a model for caring for the person with AIDS. Nursing Clinics of North America1988;23: 851–862.
14.
AngellM. The doctor as double agent. Kennedy Institute of Ethics Journal1993;3: 279–286.
15.
EmanuelEJBrettAS. Managed competition and the patient-physician relationship. New England Journal of Medicine1993;329: 879–882.
16.
PellegrinoED. Rationing health care: the ethics of medical gatekeeping. Journal of Contemporary Health Law and Policy1986;2: 23–45.
17.
EisenbergJM. The internist as gatekeeper. Preparing the general internist for a new role. Annals of Internal Medicine1985;102: 537–543.
18.
HillmanALPaulyMVKersteinJJ. How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations?New England Journal of Medicine1989;321: 86–92.
19.
Anonymous. HMO for AIDS. AIDS Policy Law1997;12: 12.
20.
RuanePJIdaJZakowskiPCSokolovRJUmanSJDalyR. Impact of newer antiretroviral (ARV) therapies on inpatient and outpatient utilization of healthcare resources in patients with HIV. 4th Conference on Retroviruses and Opportunistic Infection, January 22–26, 1997. Washington DC: 1997;112 (abstract no. 262).
21.
CaponeADavidsJ. ‘Health Choices’ is neither: women fighting forced managed care in Philadelphia. National Conference on Women and HIV. May 4–7, 1997: IKK (abstract no. P2.69).
22.
FarnhamPG. Defining and measuring the costs of the HIV epidemic to business firms. Public Health Reports1994;108: 313–318.
23.
FreedbergKAScharfsteinJASeageGRIIILosinaEWeinsteinMCCravenDE. The cost-effectiveness of preventing AIDS-related opportunistic infections. Journal of the American Medical Association1998;279: 130–136.
24.
Anonymous. Is managed care a cure for financing treatment?AIDS Alert1995;10: 69–70.
25.
ChrystieILZanderLTilzeyAWolfeCDAKenneyABanatvalaJE. Is HIV testing in antenatal clinics worthwhile? Can we afford it?AIDS Care1995;7: 135–145.
26.
OppenheimerGMPadgugRA. AIDS: the risks to insurers, the threat to equity. Hastings Center Report1986: 16 (Oct.): 18–22.
27.
RosnerF. Ethics of managed care. Mount Sinai Journal of Medicine1977;64: 8–19.
28.
TwymanDMLibbusMK. Case-management of AIDS clients as a predictor of total inpatient hospital days. Public Health Nursing1994;11: 406–411.
29.
EpsteinAM. Evaluating the cost-effectiveness of pharmacologic therapy: where we've been and where we're going. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology1995;10 (Suppl. 4): S1–S5.
30.
BozzetteSA. Specific considerations for cost-effectiveness studies in AIDS. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology1995;10 (Suppl. 4): S23–S27.
31.
KatzMHMarxRDouglasMJrBolanGAParkMSGurleyRJ. Insurance type and satisfaction with medical care among HIV infected men. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology1997;14: 35–43.
32.
BradyACleelandCGoldsteinGLefkowitzMLinden MalekPMartensG. Pain management guidelines implications for managed care — a roundtable discussion. Medical Interface1997, (Suppl.): 10–32.
33.
MontoyaIDCarlsonJWRichardAJGoodpasterWA. Managed care, cost effectiveness, and rehabilitation: the case of HIV. Rehabilitation Nursing1997;22: 7–13, 19.
34.
Anonymous. Medicaid: the system and how to use it. P.I.Perspectives1997;March (no. 21): 18–20.
35.
HavensPLCueneBEWatersDHandJChusidMJ. Structure of a primary care support system to coordinate comprehensive care for children and families infected/affected by human immunodeficiency virus in a managed care environment. Pediatric Infectious Disease Journal1997;16: 211–216.
36.
Anonymous. Health officials argue that generalists can treat HIV. AIDS Alert1997;12: 104–105.